Regarding the decision taken in September 2019 to conduct a partial review of TA375 for patients with moderate disease only https://www.nice.org.uk/guidance/ta375/evidence/review-decision--september-2019-6904907821?tab=evidence, the appraisal is now anticipated to begin during March 2020, with an anticipated evidence submission deadline to NICE of April 2020.
For further information please visit the NICE webpage: https://www.nice.org.uk/guidance/proposed/gid-ta10586